What effect has the new antipsychotic Latuda had in patients with psychosis? Is a mood stabilizer as an adjunctive therapy necessary for schizophrenia or is the use of an antipsychotic alone sufficient?
In this video segment, Dr. Peter Buckley addresses 2 questions:
• What factors do you consider when you offer depot medications to a patient with schizophrenia?
• What can be done to encourage the use of depot medications?
In this video, international expert on schizophrenia, Peter F. Buckley, MD, gives an overview of what's new in schizophrenia and discusses the state-of-the-art of diagnosis and management of this complex and challenging disorder.